Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Clinical Research > September 30, 2010

      Diabetes drug Avandia to be monitored in Shanghai


      Shanghai officials are to closely monitor adverse reactions to an anti-Diabetes drug following concerns over the risk of Heart Disease.

      The use of Avandia has been significantly restricted in the United States and sales in Europe are being suspended.

      Shanghai's Food and Drug Administration said it would be cooperating with local health authorities to watch out for any problems in the city.

      It asks GlaxoSmithKline, the drug's producer, to collect and report on any cases of adverse reactions in the city.

      The US FDA restricts the use of Avandia to patients who can't control their diabetes with any other medicine or to current users who are benefiting from the drug.

      Last Thursday, the European Medicines Agency recommended suspension of marketing authorization for Avandia and another two GlaxoSmithKline anti-diabetes drugs - Avandamet and Avaglim - with the same ingredient, rosiglitazone. These medicines will stop being available in Europe within the next few months, the agency said.

      Dr Jia Weiping, director of the Shanghai Diabetes Institute, said the moves had aroused the concern of the State Food and Drug Administration, which will meet today to discuss the drug's use and adverse reaction supervision across the country.

      "Local patients shouldn't panic about the news of Avandia, since its dosage for Chinese patients is much lower than that for US and European patients," Jia said. "In the West, the drug is prescribed by general physicians while the drug in China is used by specialists after careful consideration of the patient's medical history and is not used for patients with cardiovascular problems."

      She said Avandia was a popular diabetes drug in China and there had been no reports of serious side effects so far.

      GlaxoSmithKline said it had stopped marketing Avandia in all countries including China after regulators withdrew the product in Europe and restricted its use in the US. The British drug maker had notified China's FDA of the latest situation. It will also release a notice to patients.

      "We have not received any adverse reaction reports from Chinese patients yet and we suggest patients do not stop taking the medicine before seeking advice from doctors," said a GlaxoSmithKline official.

      Sep 30, 2010


      Share this Article!

    Back to top^